ID

40843

Beskrivning

Study ID: 103933 Clinical Study ID: NKV103933 Study Title: A non-randomised, open label, two period cross-over study to determine the excretion balance and metabolic disposition of [14C]-GW679769, administered as single doses of an oral solution and an intravenous infusion to healthy male subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced Protocol ID: NKV103933 The eligibility to participate was determined during a screening visit within 21 days prior to first dosing day. The study consisted of two dosing periods, each consisting of predose visit, monitoring after dose administration and prior to discharge visit. Dosing periods were separated by a wash-out period of 43 days. The Concomitant Medications has to be filled in at the Screening Visit and throughout the study whenever a change in patient's medication is made.

Nyckelord

  1. 2020-05-24 2020-05-24 -
Rättsinnehavare

GlaxoSmithKline

Uppladdad den

24 maj 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Study of Casopitant Pharmacokinetics in Healthy Males, NKV103933

Concomitant Medications

Administrative Data
Beskrivning

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Beskrivning

Subject Identifier

Datatyp

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Beskrivning

Visit Date

Datatyp

date

Alias
UMLS CUI [1]
C1320303
Document Type
Beskrivning

Document Type

Datatyp

text

Alias
UMLS CUI [1]
C1547673
Concomintant Medications
Beskrivning

Concomintant Medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject during the study?
Beskrivning

If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008976
List of Concomintant Medications
Beskrivning

List of Concomintant Medications

Alias
UMLS CUI-1
C2347852
Drug Name
Beskrivning

Concomitant Agent Drug Name

Datatyp

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
Unit Dose
Beskrivning

Concomitant Agent Unit Dose

Datatyp

float

Alias
UMLS CUI [1]
C2826646
Units
Beskrivning

Concomitant Agent Unit

Datatyp

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0439148
Frequency
Beskrivning

Concomitant Agent Frequency

Datatyp

text

Alias
UMLS CUI [1]
C2826654
Route
Beskrivning

Concomitant Agent Drug Administration Routes

Datatyp

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013153
Reason for Medication
Beskrivning

Concomitant Agent Indication

Datatyp

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Start Date
Beskrivning

Concomitant Agent Start Date

Datatyp

date

Alias
UMLS CUI [1]
C2826734
Start Time
Beskrivning

Concomitant Agent Start Time

Datatyp

time

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1301880
Taken Prior to Study?
Beskrivning

Concomitant Agent Taken Prior to Study?

Datatyp

boolean

Alias
UMLS CUI [1]
C2826667
Stop Date
Beskrivning

Concomitant Agent Stop Date

Datatyp

date

Alias
UMLS CUI [1]
C2826744
Stop Time
Beskrivning

Concomitant Agent Stop Time

Datatyp

time

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1522314
Ongoing Medication?
Beskrivning

Concomitant Agent Ongoing

Datatyp

boolean

Alias
UMLS CUI [1]
C2826666

Similar models

Concomitant Medications

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item
Document Type
text
C1547673 (UMLS CUI [1])
Code List
Document Type
CL Item
Screening (Screening)
(Comment:en)
CL Item
Treatment Period (Treatment Period)
Item Group
Concomintant Medications
C2347852 (UMLS CUI-1)
Concomintant agents taken during the study
Item
Were any concomitant medications taken by the subject during the study?
boolean
C2347852 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Item Group
List of Concomintant Medications
C2347852 (UMLS CUI-1)
Concomitant Agent Drug Name
Item
Drug Name
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
Concomitant Agent Unit Dose
Item
Unit Dose
float
C2826646 (UMLS CUI [1])
Concomitant Agent Unit
Item
Units
text
C2347852 (UMLS CUI [1,1])
C0439148 (UMLS CUI [1,2])
Concomitant Agent Frequency
Item
Frequency
text
C2826654 (UMLS CUI [1])
Concomitant Agent Drug Administration Routes
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Concomitant Agent Indication
Item
Reason for Medication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Concomitant Agent Start Date
Item
Start Date
date
C2826734 (UMLS CUI [1])
Concomitant Agent Start Time
Item
Start Time
time
C2347852 (UMLS CUI [1,1])
C1301880 (UMLS CUI [1,2])
Concomitant Agent Taken Prior to Study?
Item
Taken Prior to Study?
boolean
C2826667 (UMLS CUI [1])
Concomitant Agent Stop Date
Item
Stop Date
date
C2826744 (UMLS CUI [1])
Concomitant Agent Stop Time
Item
Stop Time
time
C2347852 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Concomitant Agent Ongoing
Item
Ongoing Medication?
boolean
C2826666 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial